Lite Strategy Inc. (LITS)
NASDAQ: LITSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LITS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $23.99M
- EPS (TTM)
- -$1.38
- Dividend yield
- None
- Ex-dividend date
- Nov 16, 2023
- 52-week range
- 0.69 – 1.99
- Day range
- 0.7901 – 0.865
- Volume / Avg
- 177.44K / 524.33K
- Beta
- —
- Shares outstanding
- 29.88M
52-week range
LITS stock today
Lite Strategy (LITS) closed at $0.8026 on Nov 20, down 4.03% (-$0.0337), versus the S&P 500's 3.70% decline. Trading was light, with 177.44K shares changing hands, about 34% of the average daily volume. At this level, LITS sits near the bottom of its 52-week range of $0.69 to $1.99: 59.7% below the high, set on Nov 26, 2025 and 16.3% above the low.
LITS is down 39.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 52.8%. Lite Strategy has posted a net loss over the last twelve months (EPS of -$1.38), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Lite Strategy
Company profileLite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Employees
- 5
- IPO year
- 2003
- Website
- litestrategy.com
Financial highlights
Full financialsLite Strategy reported a net loss of $71.2 million, compared with a loss of $15.9 million a year earlier. Diluted earnings per share came in at -$2.06.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $65.30M | $48.82M | $40.70M |
| Growth | — | -100.00% | +33.76% | +19.95% | +16.96% |
| Net income | $-71.15M | $-15.95M | $18.00M | $-32.00M | $-54.00M |
| EPS (diluted) | $-2.06 | $-2.39 | $2.67 | $-4.78 | $-9.99 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $0.48 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.75
- Ex-dividend date
- Nov 16, 2023
LITS news
All LITS newsLite Strategy peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SCYXSCYNEXIS Inc. | 2.38 | -8.64% | $23.69M | vs LITS |
| ABVCABVC BioPharma Inc. | 0.8663 | -1.56% | $23.37M | vs LITS |
| IXHLIncannex Healthcare Inc. | 1.86 | +6.90% | $23.34M | vs LITS |
| RMTIRockwell Medical Inc. | 5.82 | -7.03% | $23.12M | vs LITS |
| IMMPImmutep Limited ADR | 3.11 | -9.06% | $22.92M | vs LITS |
| CRVOCervoMed Inc. | 1.46 | +9.77% | $22.09M | vs LITS |
| BCTXBriaCell Therapeutics Corp. | 3.06 | -3.32% | $26.72M | vs LITS |
| TELOTelomir Pharmaceuticals Inc. | 0.364 | -17.24% | $26.82M | vs LITS |
Indexes, lists and sector
Lite Strategy stock FAQ
What is Lite Strategy's stock price today?
LITS last traded at $0.8026 as of Nov 20, 4:00 PM EST, down 4.03% on the day. Prices are delayed at least 15 minutes.
Does Lite Strategy pay a dividend?
Yes. Lite Strategy pays $0.00 per share annually. The most recent dividend of $1.75 had an ex-dividend date of Nov 16, 2023.
Has LITS ever split its stock?
Yes. The most recent LITS stock split was a 1-for-20 split on Apr 17, 2023, one of 3 splits on record.
What is the LITS 52-week high?
The 52-week high for LITS is $1.99 and the 52-week low is $0.69. The stock is currently 59.7% below its high.